European Journal of Clinical Pharmacology 55 (1999): 349–52.
Gulyas, B., et al. «Brain Uptake and Plasma Metabolism of [11C] Vinpocetine: A Preliminary PET Study in a Cynomolgus Monkey», Journal of Neuroimaging 9 (1997): 217–22.
Sitges, М., and V. Nekrassov, «Vinpocetine Prevents 4-Aminopyridine-Induced Changes in the EEG, the Auditory Brainstem Responses and Hearing», Clinical Neurophysiology 115, no. 12 (December 2004): 2711–17.
Thai, L. J., et al. «The Safety and Lack of Efficacy of Vinpocetine in Alzheimer’s Disease», Journal of the American Geriatrics Society 37 (1989): 515–20.
Fletcher, R. H., and К. M. Fairfield, «Vitamins for Chronic Disease Prevention in Adults: Clinical Applications», Journal of the American Medical Association 287, no. 23 (June 19, 2002): 3127–29.
Aarsand, A. К., and S. M. Carlsen, «Folate Administration Reduces Circulating Homocysteine Levels in NIDDM Patients on Long-term Metformin Treatment», Journal of Internal Medicine 244 (1998): 169–74.
Anon., «How Folate Fights Disease», Nature Structural Biology 6 (1999): 293–94.
Baik, H. W., and R. M. Russell, «Vitamin B12 Deficiency in the Elderly», Annual Review of Nutrition 19 (1999): 357–77.
Berry, R. J., et al. «Prevention of Neural-Tube Defects with Folic Acid in China», New England Journal of Medicine 341 (1999): 1485–90.
Bottiglieri, T., «Folate, Vitamin B12, and Neuropsychiatric Disorders», Nutrition Reviews 54 (1996): 382–90.
Boushey, C. J., et al. «A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease. Probable Benefits of Increasing Folic Acid Intakes», Journal of the American Medical Association 274 (1995): 1049–57.
Clarke, R., et al. «Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer’s Disease», Archives of Neurology 55 (1998): 1449–55.
Coppen, A., and J. Bailey, «Enhancement of the Antidepressant Action of Fluoxetine by Folic Acid: A Randomized, Placebo-Controlled Trial», Journal of Affective Disorders 60 (2000): 121–30.
Coppen, A., S. Chaudhry, and C. Swade, «Folic Acid Enhances Lithium Prophylaxis», Journal of Affective Disorders 10 (1986): 9–13.
Czeizel, A. E., and I. Dudas, «Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation», New England Journal of Medicine 327 (1992): 1832–35.
Guilarte, Т. R., «Vitamin B6 and Cognitive Development: Recent Research Findings from Human and Animal Studies», Nutrition Reviews 51 (1993): 193–98.
Homocysteine Lowering Trialists’ Collaboration, «Lowering Blood Homocysteine with Folic Acid Based Supplements: Meta-Analysis of Randomized Trials», British Medical Journal 316 (1998): 894–98.
Leklem, J. E., «Vitamin B6», in M.E. Shils et al. eds, «Modern Nutrition in Health and Disease», 9th ed. (Baltimore: Williams and Wilkins, 1999), 413–21.
Lindenbaum, J., et al. «Neuropsvchiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis», New England Journal of Medicine 318 (1988): 1720–28.
McCaddon, A., and C. L. Kelly, «Familial Alzheimer’s Disease and Vitamin B12 Deficiency», Age and Ageing 23 (1994): 334–37.
Rimm, E. B., et al. «Higher Intake of Folate and Vitamin B6 Is Associated with Low Rates of Coronary Artery Disease in Women», Journal of the American Medical Association 279 (1998): 359–64.
Snowdon, D. A., et al. «Serum Folate and the Severity of Atrophy of the Neocortex in Alzheimer Disease: Findings from the Nun Study», American Journal of Clinical Nutrition 71 (2000): 993–98.
Sumner, A. E., et al. «Elevated Methylmalonic Acid and Total Homocysteine Levels Show High Prevalence of Vitamin B12 Deficiency After Gastric Surgery», Annals of Internal Medicine 124 (1996): 469–76.
Weir, D. G., and J. M. Scott, «Brain Function in the Elderly: Role of Vitamin B12 and Folate», British Medical Bulletin 55 (1999): 669–82.
Wyatt, К. M., et al. «Efficacy of Vitamin B12 in the Treatment of Premenstrual Syndrome: Systemic Review», British Medical Journal (1999): 1375–81.
Age-Related Eye Disease Study Research Group, «A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins С and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8», Archives of Ophthalmology 119, no. 10 (October 2001): 1417–36.
«Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids» (Washington, D.C.: National Academy Press, 2000).
Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287, no. 24 (June 26, 2002): 3223–29.
Gray, S. L., et al. «Is Antioxidant Use Protective of Cognitive Function in the Community-Dwelling Elderly?» American Journal of Geriatric Pharmacotherapy I, no. 1 (September 2003): 3–10.
Lykkesfeldt, J., et al. «Ascorbate Is Depleted by Smoking and Repleted By Moderate Supplementation: A Study in Male Smokers and Nonsmokers with Matched Dietary Intakes», American Journal of Clinical Nutrition 71 (2000): 530–36.
Voko, Z., et al. «Dietary Antioxidants and the Risk of Ischemic Stroke: The Rotterdam Study», Neurology 61, no. 9 (November 11, 2003): 1273–75.
Adler, L. A., et al. «Vitamin E Treatment for Tardive Dyskinesia», Archives of General Psychiatry 56 (1999): 836–41.
Anderson, D. К., T. R. Waters, and E. D. Means, «Pretreatment with Alpha-Tocopherol Enhances Neurologic Recovery After Experimental Spinal Cord Compression Injury», Journal of Neurotrauma 5, no. 61 (1998): 61–67.
Aslam, A., et al. «Vitamin E Deficiency Induced Neurological Disease in Common Variable Immunodeficiency: Two Cases and a Review of the Literature of Vitamin E Deficiency», Clinical Immunology 112, no. 1 (July 2004): 24–29.
Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287, no. 24 (June 26, 2002): 3223–29.
GISSI-Prevenzionc Investigators, «Dietary Supplementation with N-3 Polyunsaturated Fatty Acids and Vitamin E after Myocardial Infarction: Results of the GlSSI-Prevenzioni Trial», Lancet 354 (1999): 447–55.
Gray, S. I., et al. «Predictors of Nutritional Supplement Use by the Elderly», Pharmacotherapy 16, no. 4 (July-August 1996): 715–20.
Gray, S. L., et al. «Is Antioxidant Use Protective of Cognitive Function in the Community-Dwelling Elderly?» American Journal of Geriatric Pharmacotherapy 1, no. 1 (September 2003): 3–10.
Grundman, M., «Vitamin E and Alzheimer’s Disease: The Basis for Additional Clinical Trials», American Journal of Clinical Nutrition 71 (2000): 630S-36S.
Miller, E. R., Ill, et al. «Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality», Annals of Internal Medicine (January 4, 2005): 37–46.
Rimm, E. B., et al. «Vitamin E Consumption and the Risk of Coronary Heart Disease in Men», New England Journal of Medicine 328, no. 20 (May 20, 1993): 1450–56.
Rutten, B. P., et al. «Antioxidants and Alzheimer’s Disease: From Bench to Bedside (and Back Again)», Current Opinion in Clinical Nutrition and Metabolic Care 5, no. 6 (November 2002): 645–51.
Shoulson, I., «DATATOP: A Decade of Neuroprotective Inquiry. Parkinson Study Group. Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism», Annals of Neurology 44, no. 3 suppl. 1 (1998): S160–66.
Stampfer, M. J., et al. «Vitamin E Consumption and the Risk of Coronary Disease in Women», New England Journal of Medicine 328, no. 20 (May 20, 1993): 1444–49.
Iraber, M. G., «Which Form of Vitamin E, Alpha-or Gamma-Tocopherol, Is Better?» Linus Pauling Institute Report (2002).
Voko, Z., et al. «Dietary Antioxidants and the Risk of Ischemic Stroke: The Rotterdam Study», Neurology 61, no. 9 (November 11, 2003): 1273–75.
Wu, A., Z. Ying, and F. Gomez-Pinilla, «The Interplay Between Oxidative Stress and Brain-Derived Neurotrophic Factor Modulates the Outcome of a Saturated Fat Diet on Synaptic Plasticity and Cognition», European Journal of Neuroscience 19, no. 7 (April 2004): 1699–707.
Bell, К. М., et al. «S-Adenosylmethionine Treatment of Depression: A Controlled Clinical Trial», American Journal of Psychiatry 145, no. 9 (1988): 1110–14.
Bell, К. М., et al. «S-Adenosylmethionine Blood Levels in Major Depression: Changes with Drug Treatment», Acta Neurologica Scandinavica 154 (Suppl.) (1994): 15–18.
Berlanga, C., et al. «Efficacy of S-Adenosyl-L-Methionine in Speeding the Onset of Action of Imipramine», Psychiatry Research 44, no. 3 (1992): 257–62.
Glorioso, S., et al. «Double-Blind Multicentre Study of the Activity of S-Adenosylmethionine in Hip and Knee Osteoarthritis», International Journal of Clinical Pharmacology Research 5, no. 1 (1985): 39–49.
Jacobsen, S., B. Danneskiold-Samsoe, and R. B. Andersen, «Oral S-Adenosylmethionine in Primary Fibromyalgia. Double-Blind Clinical Evaluation», Scandinavian Journal of Rheumatology 20, no. 4 (1991): 294–302.
Kagan, B. L., et al. «Oral S-Adenosylmethionine in Depression: A Randomized, Double-Blind, Placebo-Controlled Trial», American Journal of Psychiatry 147, no. 5 (1990): 591–95.